Leading researcher honoured
Associate Professor Eric Chow from the Melbourne Sexual Health Centre and Monash University was recently awarded the 2020 Commonwealth Health Minister’s Award for Excellence in Health and Medical Research.
Visitor information – Everything you need to know about visiting our sites.
Associate Professor Eric Chow from the Melbourne Sexual Health Centre and Monash University was recently awarded the 2020 Commonwealth Health Minister’s Award for Excellence in Health and Medical Research.
The Alfred has banded together with a private IVF company to save a patient's chance of having children after he was diagnosed with testicular cancer.
With COVID-19 still transmitting within community, Alfred Health allergy experts are urging hay fever sufferers not to ignore their symptoms as spring approaches.
Alfred Cancer Trials (ACT) has begun testing two new Phase 1 cancer drugs, treating the first patients in the world on these trials.
A statement from Professor Andrew Way, Chief Executive of Alfred Health, regarding visitor restrictions.
Respiratory specialists at The Alfred are urging people with asthma to review their medication after new research found one quarter of people who use inhaler controllers receive potentially toxic cumulative doses of oral corticosteroid.
Artificial intelligence (AI) could soon become a powerful tool in skin cancer assessment. The Victorian Melanoma Service is currently conducting a trial into the effectiveness of the technology.
The first specialist clinic in Australia to study the impact of COVID-19 on the heart is opening at The Alfred.
Victoria’s State of Emergency (SOE) measures resulted in almost 40 per cent less people presenting to Alfred Health’s emergency departments earlier this year, prompting doctors to issue an urgent call for people to continue seeking medical care if they need it.
Making up 80 per-cent of all brain tumours in adults, gliomas such as glioblastoma (GBM) are the most common and aggressive form of brain cancer. Killing more people under forty than any other cancer, a quarter of a million people die every year from these tumours – despite current treatment options the average survival for a GBM is only 14-15 months after diagnosis